RCDS and Partners Bring Light and Hope to Leprosy Patients with Solar Power Plant and Relief Aid

Our Bureau

The Rotary Club of Delhi South (RCDS) has partnered with Lepra and Assets Care and Reconstruction Enterprise Ltd (ACRE) to launch an on-grid solar power plant at the Mother Teresa Home in Tahirpur, Delhi. The project aims to provide a sustainable source of energy for leprosy patients and their families, improving their quality of life. The solar power plant was inaugurated by Hon’ble Member of Parliament, Mr. Manoj Tiwari, who also distributed tricycles to the patients.

Leprosy remains one of the most underreported and misunderstood diseases globally, with India accounting for 54% of new cases detected in 2020-21. To improve medical care, raise awareness, and dispel social stigma surrounding the disease, RCDS, along with its partners, takes a multi-pronged approach. The Leprosy Control Project, launched in 2019, works towards uplifting the lives of more than 1500 leprosy patients and their families in Delhi NCR.

Apart from the solar power plant, RCDS has donated relief aid and tricycles to the patients, which will help them lead a more comfortable and independent life. The tricycles will enable the patients to move around more easily and regain their independence.

With this green initiative, RCDS has set an example for other organizations to follow in their endeavor to improve the quality of life for marginalized communities. The project highlights the importance of sustainable energy solutions in improving the health and well-being of society’s most vulnerable groups. RCDS, along with its partners, is making significant progress towards making India a leprosy-free nation while empowering the leprosy patients with a sustainable source of energy.


Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Cancer Research UK-funded trial reveals chemotherapy before surgery can reduce colon cancer recurrence risk by 28%

A groundbreaking Cancer Research UK-funded clinical trial has revealed that administering chemotherapy before surgery can reduce the risk of colon cancer recurrence. The FOxTROT trial was led by scientists from the University of Birmingham and the University of Leeds and involved 1,053 colon cancer patients from 85 hospitals across the […]

Subscribe Now